Coral Drugs began its operations in 1996. Our founder, Mr. B.K. Bhuwania, started the company with a clear vision to make a difference and to offer products complying with the highest quality. Those principles are still applicable in our lives, even today, as we conduct our operations.

Our journey began by offering just a couple of Anti-Neoplastic API’s and gradually product differentiation was introduced by introducing Steroids and Hormones to our manufacturing lines.

In the early part of the 2000s, our focus shifted to introducing strict quality management systems into our production processes. This rapidly led us into implementing cGMP production standards across our operations. As a result, we were first audited by the US FDA in  2010 and by the European Union in 2013.

We continue to prove and test our quality systems by regular audits conducted by our State and Central Drug Department (India), The United States Food and Drug Administration, the European Union, and other reputed regulatory bodies. Additionally, we welcome all our clients to audit our facilities.

Coral Drugs operates six manufacturing blocks that cater to specific therapeutic categories. These facilities are well supported by various and independent departments such as Quality Control, Quality Assurance, Engineering Services, IT, Human Resources, Commercial, and Finance.